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The number of patients with diabetes is on an increasing trend, thus leading to the belief that diabetes will 
be the largest medical problem of the 21st century. Islet transplantation can improve glycometabolic control 
in patients with type 1 diabetes. We studied the viability of Rho-associated protein kinase (ROCK) inhibitor 
Y-27632 in a culture system in vitro on freshly isolated rat islets. Islet isolation was conducted on a Lewis rat, 
and studies of culture solutions were split into two groups, one group using ROCK inhibitor Y-27632, and 
another without. On the seventh day of culture, we evaluated the differences for the cell morphology, viability, 
and insulin secretion. The Y-27632 group maintained form better than the group without Y-27632. With strong 
expression of Bcl-2 observed with the Y-27632 group, and expression suppressed with Bax, inhibition of apop-
tosis by Y-27632 was confirmed. The Y-27632 group predominantly secreted insulin. For islet transplantation, 
Y-27632 inhibited cell apoptosis in a graft and was also effective in promoting insulin secretion. We were able 
to confirm effective morphological and functional culture maintenance by separating islets from a rat and  
adding ROCK inhibitor Y-27632 to the medium. 
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developed, and their effectiveness has been recognized 
(11,17–21,23). However, there is an inadequate number 
of donors for such transplant procedures, and even if the 
transplant procedure were to be successful, the patients 
must continue to take medication as part of the immuno-
suppressive therapy, and various problems occur due to 
the side effects of the medication, such as carcinogenic 
effects and compromised immune systems. As an alterna-
tive to transplant surgery, we are working on bioartificial 
pancreas (BAP) development as an innovative, next- 
generation therapy. Not only clinical medicine but also 
cell biology and the help of medical engineering are essen-
tial for the development of BAP as a practical application. 
From the results (12,26) of the bioartificial liver develop-
ment, a whole-blood perfusion type BAP was developed 
by combining poly(amino acid)-urethane (PAU)-coated 
high-density polyethylene (HDPE) and ethylene vinyl 
alcohol (EVAL) hollow fiber, and its usefulness on a pig 
INTRODUCTION
The number of patients with diabetes is on an increas-
ing trend, and the International Diabetes Federation 
(IDF) conducted a survey of 212 countries and regions. 
By October 2009, the number of diabetes patients 
exceeded 285,000,000, of which 4,870,000 had type 1 
diabetes (40% of type 2 diabetes patients are believed to 
require insulin), and this is expected to increase 1.5 times 
to 435,000,000 by 2030, thus leading to the belief that 
diabetes will be the largest medical problem of the 21st 
century (11). Therefore, measures to fight diabetes are an 
immediate problem in the medical world. The standard 
treatment so far for type 1 diabetes has been to conduct 
intensive insulin therapy, but this has had limited effec-
tiveness. For cases with glycemic control problems or 
acute hypoglycemia due to side effects and cases asso-
ciated with chronic renal failure, transplantation pro-
cedures such as pancreas or islet transplants have been 
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model pancreatectomy resection has been reported (9). 
Although effective in intensive care unit (ICU) therapy 
in the acute phase, the development of an implanted, 
wearable-type BAP rather than an external type is needed 
when considering the quality of life (QOL) of chronic 
patients. At present, a bag-type device has been created 
with a PAU-coated HDPE and an EVAL flat membrane, 
and satisfactory biocompatibility from implant experi-
ments in the acute phase has been confirmed with animal 
experiments using rats (32). The device has an immune 
isolation effect and therefore not only eliminates the 
need for immunosuppression but could also allow for 
the use of pancreatic islets from other animals and thus 
could supplement the shortage of human islet donors. 
Compared to the operation of transplanting a pancreatic 
islet to the liver of a living body, the operation of fill-
ing the device with living cells will lower the function as 
well as threaten the lifetime of the cells. In fact, although 
islets experience various stresses from the separation pro-
cedure, there are additional stresses within the device’s 
bag such as the cessation of nutritional factors, oxidative 
stress, agitation death, and low oxygen, resulting in apop-
tosis several days after transplantation.
The creation of an environment within the device sim-
ilar to the living body’s natural environment is therefore 
essential. In order to accomplish this, the integration of 
extracellular matrix engineering will also be required. So 
far, we have obtained satisfactory results by applying a 
certain puramatrix with a self-assembling gel to the islet 
culture. It is generally known that when cells are stressed 
during separation and culturing, the activation of Rho is 
triggered, and the activated Rho causes Rho-associated 
protein kinase (ROCK) activation. The activated ROCK 
will phosphorylate the myosin light chain (MLC) and 
cause cell contraction, thus leading to apoptosis by mem-
brane blebbing (13). To prevent such cell death, and as 
a basic study on lengthening the lifetime of the cells in 
BAP devices, we studied the viability of ROCK inhibitor 
Y-27632 in a culture system using PAU-coated HDPE in 
vitro on freshly isolated rat islets.
MATERIALS AND METHODS
Isolation and Culture of Rat Islets
Islet isolation was conducted on three 300- to 400-g 
male Lewis rats (8–15 weeks old, Japan SLC Inc., Sizuoka, 
Japan). All animal studies were approved by the Institutional 
Animal Care and Use Committee of Okayama University. 
All surgical techniques were conducted under inhaled 
anesthesia of diethyl ether (100 mg/kg; Sigma-Aldrich, 
St. Louis, MO, USA). An abdominal midline incision 
was made to the rat’s abdomen, the duodenal papilla was 
clamped, and a 24-gauge plastic cannula (Terumo, Tokyo, 
Japan) was affixed to the ductus hepaticus communis. Ten 
milliliters of pre-iced Liberase RI (Roche Diagnostics, 
Tokyo, Japan) working enzyme solution (a collagenase) 
was injected, and the pancreas was allowed to swell. After 
the rat was euthanized by exsanguination, the swollen 
pancreas was completely removed and immersed in 5 ml 
of working enzyme solution and placed on ice. Islet iso-
lation was conducted as described previously (18). The 
dithizone (Sigma-Aldrich)-stained islets were observed, 
and the number of islets was measured.
The viability of the separated islets was immediately 
measured. Measurement was conducted according to the 
instructions of the LIVE/DEAD Viability/Cytotoxicity 
Kit (Life Technologies, Carlsbad, CA, USA). Observation 
was conducted by fluorescence microscope (Olympus, 
Tokyo, Japan) with green calcein-AM staining depict-
ing living cells and red ethidium homodimer-1 depicting 
dead cells. Viability was determined by analyzing the area 
ratio of live/dead cells using the Image J area calculation 
software (NIH, Bethesda, MD, USA).
Culture Conditions
PAU-coated HDPE (Kuraray, Tokyo, Japan) that 
serves as a foundation for cells within the bioartificial 
pancreas was used, and studies of culture solutions 
were split into two groups, a control group (group 1) 
and a test group (group 2) using the ROCK inhibitor 
Y-27632. Glucose (5.5 mM), 10% fetal bovine serum (FBS) 
(Thermo Scientific, Kanagawa, Japan), and 1% penicillin/ 
streptomycin (Sigma-Aldrich) were added to Roswell Park 
Memorial Institute medium (RPMI; Life Technologies), 
and 10 μM Y-27632 (Millipore, Billerica, MA, USA) 
was added as appropriate; after 24 h, the medium was 
exchanged for a medium not containing Y-27632. Using 
a six-well plate (Corning Japan, Tokyo, Japan), each well 
was seeded with 200 islet equivalents (IEQs) of islets 
and cultured for 7 days at 37°C and 5% CO2.
Western Blot
The presence of ROCK proteins in the rat islets was 
confirmed using a Western blot method. It is believed that 
ROCK1 exists in all tissue except the prostate gland, and 
ROCK2 exists in the brain and skeletal muscle (16,24). 
After three washings with PBS, cells were sonicated 
(Tomys Seiko Co., LTD, Tokyo, Japan). Then, micrograms 
of cell extracts were fractionated by 10% sodium dodecyl 
sulfate–polyacrylamide gel electrophoresis (SDS-PAGE; 
Sigma-Aldrich) and transferred to polyvinylidenefluo-
ride membranes (Immun-Blot PVDF Membrane; Bio-
Rad, Hercules, CA) using transfer buffer containing 20% 
methanol, 25 mmol/L Tris base, and 192 mmol/L glycine 
(300 mA, 2 h; all from Sigma-Aldrich). After block-
ing at room temperature for 1 h in 50 mmol/L Tris-HCl, 
150 mmol/L NaCl, and 0.1% Tween-20 [Tris-buffered 
saline with Tween (TBST); all from Sigma-Aldrich] with 
5% nonfat dry milk (Sigma-Aldrich), the membranes were 
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incubated overnight at 4°C in TBST using 5% nonfat dry 
milk containing primary antibodies (BD Biosciences, San 
Jose, CA, USA) of ROCK1 and ROCK2, and then for 1 h 
at room temperature in TBST with 5% nonfat dry milk 
containing secondary antibody coupled to horseradish 
peroxidase (HRP; BD Biosciences). Coomassie Brilliant 
Blue (CBB) staining (Sigma-Aldrich) was performed to 
evaluate protein expression.
MTT Assay
MTT assay was used for determination of cell growth 
rate. Vybrant® MTT Cell Proliferation Assay Kit (Life 
Technologies Japan, Tokyo, Japan), which provides a 
simple method for determination of cell number using 
standard microplate absorbance readers (Bio-Rad) was 
used in this study. The MTT [3-(4,5-dimethylthiazol-2-
yl)-2,5-diphenyltetrazolium bromide] assay involves the 
conversion of the water-soluble MTT to an insoluble for-
mazan. The formazan is then solubilized, and the concen-
tration is determined by optical density at 570 nm. The 
result was a sensitive assay with excellent linearity up to 
approximately 106 cells per well.
Assessment of Islet Morphology
On the seventh day of culture, the suspended cells and 
cells from the nonwoven fabric were extracted as much as 
possible, and the cell form was evaluated using a phase-
contrast microscope (Olympus). In addition, the ultrafine 
structure was evaluated in the same manner using a scan-
ning electron microscope (SEM) (Hitachi, Tokyo, Japan). 
For scanning electron microscopy, the samples were fixed 
with 4% paraformaldehyde and 0.1% glutaraldehyde in 
0.1 M phosphate buffer, pH 7.4 (all from Sigma-Aldrich). 
The samples were embedded in LR White (London Resin 
Company, London, UK).
Insulin Secretion
Islet function was assessed by monitoring the insulin 
secretory response of the islets during glucose stimula-
tion. Briefly, 1,200 IEQs were incubated with either 2.8 
or 25 mM glucose in RPMI 1640 for 2 h at 37°C and 5% 
CO2. The supernatants were collected and insulin levels 
were determined using a commercially available enzyme-
linked immunosorbent assay (ELISA) kit (Mercodia, 
Uppsala, Sweden). The stimulation index was calculated 
by determining the ratio of insulin released from islets in 
high glucose to the insulin released in low glucose. The 
data were expressed as mean ± SE.
RT-PCR
The evaluation of apoptosis was conducted using 
RT-PCR methods. B-cell CLL/lymphoma 2 (Bcl-2) and 
Bcl2-associated X protein (Bax) gene expressions were 
observed with the RT-PCR method. Bax is a proapoptotic 
protein, and Bcl-2 is an antiapoptotic protein. The primers 
used were Bcl-2 sense 5¢-AGGATTGTGGCCTTCTTTGA 
GT, antisense 5¢-GCCGGTTCAGGTACTCAGTCAT; Bax 
sense 5¢-CAGCTCTGAACAGATCATGA, antisense 
5¢-AGCTGCCACACGGAAGAAGA; and GAPDH sense 
5¢-GGAGTCTACTGGCGTCTTCA, antisense 5¢-ATGAG 
CCCTTCCACGAT.
Transplantation of Islets and Immunostaining
As a transplant experiment, the resected rat islets were 
cultured with or without Y-27632, and after 24 h, 300 
samples were randomly selected and extracted from each 
group and were transplanted to the renal subcapsule of 
syngeneic rats (8–15 weeks old, 300–400 g, male Lewis 
rat, n = 3). Seven days later the kidneys were extracted and 
observed. Hematoxylin–eosin (H&E) staining (Sigma-
Aldrich) and insulin immunostaining were conducted. 
For immunostaining, the tissues were blocked with 10% 
serum and 0.2% Triton X-100 in PBS (all from Sigma-
Aldrich) and then incubated with primary antibody to 
mouse insulin (guinea pig polyclonal antibody to mouse 
insulin, 1:100, Abcam, Cambridge, UK) overnight at 
4°C. Cells were further incubated with secondary anti-
body (goat polyclonal antibody to guinea pig IgG-H&L, 
1:100, Abcam).
Statistics
The two groups were compared by Student’s t test. 
The differences between each group were considered 
 significant if p < 0.05.
RESULTS
ROCK Expression in Islets and  
Effect of a ROCK Inhibitor, Y-27632
Islet isolation was conducted on three rats with an aver-
age weight of 370 g, and an average of 4,441 IEQs was 
isolated from each rat with a viability of 97%. ROCK1 
and ROCK2 expression was confirmed without regard 
to the use of Y-27632 (Fig. 1A). We used a 10 μM con-
centration of Y-27632 for the rat islet culture. Although 
the optimal concentration of 10 μM is also noted in other 
articles (6,13), a confirmation that 10 μM is adequate was 
obtained from an MTT assay that was conducted with 
a dose–response curve for Y-27632, which achieved a 
plateau above 10 μM (Fig. 1B).
Scanning Electronic Microscopy
The ultrafine structure was evaluated in the same 
manner using an SEM. The islet control group showed 
variance and membrane blebbing (foaming) immediately 
after culture, and by the seventh day, cells morphed by 
stretching to the sides, indicating an irregularity in the 
margins. This membrane blebbing was inhibited in the 
Y-27632 combined group, and the normal cell form was 
maintained (Fig. 2).
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Viability
On the seventh day of each culture group, fluo-
res cence staining was conducted using a live/dead 
 viability cytotoxicity kit, and viability was determined 
by the area ratio of green areas indicating live cells 
and red areas indicating dead cells. The viability of the 
control group was on average 19.9% compared with 
68.7% for the Y-27632 group, indicating a signifi-
cantly better survival rate following Y-27632 treatment 
(Fig. 3).
Figure 2. Morphology and electronic microscopy of islets. Morphology and the ultrafine structure was evaluated using a phase-
contrast microscope and a scanning electron microscope (SEM). The Y-27632 group maintained form better than the control group 
with respect to spherical cell morphology, margin, boundary, and size. Scale bars: 200 mm.
Figure 1. Rho-associated protein kinase (ROCK) expression in islets and effect of a ROCK inhibitor, Y-27632. (A) ROCK expression 
in islets. ROCK1 and ROCK2 expression was confirmed irrespective of Y-27632. Coomassie Brilliant Blue (CBB) stain showed similar 
protein expressions between the two groups. (B) Effect of ROCK inhibitor Y-27632. A dose–response curve of different concentrations 
of Y-27632 confirmed a plateau above 10 μM, suggesting that this concentration is adequate using an MTT assay.
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Glucose-Responding Insulin Secretion
On the third day of culture, the 1-h use of low- and high-
glucose media allowed glucose stimulation to be assayed 
using an ELISA kit. The stimulation index was signifi-
cantly higher in the Y-27632 group than in the control 
group (control: 2.23 ± 0.30, n = 5; Y-27632: 3.45 ± 0.17, 
n = 5) (Fig. 4). Not only was apoptosis inhibited and cell 
form maintained, but it was found that Y-27632 was also 
useful in maintaining insulin secretion function.
Bcl-2 and Bax Expression
The expressions of proapoptotic Bax and antiapoptotic 
Bcl-2 were studied using RT-PCR as indicator of apopto-
sis. Bcl-2 was strongly expressed by the Y-27632 group, 
whereas Bax expression was reduced, suggesting apopto-
sis inhibition by Y-27632 (Fig. 5). On the other hand, Bax 
was strongly expressed in the control group, and Bcl-2 
expression was inhibited.
Islet Transplantation
Seven days after transplantation of the resected rat 
islets, the kidney was extracted and the average cell adhe-
sion area of the Y-27632 group was shown to be 8.85%, 
whereas that of the control group was 1.57%, indicating 
a predominantly large adhesion area following Y-27632. 
H&E staining showed that the graft of the nonuse group 
had sparse and random adhesion compared with con-
sistent thickness and regular adhesion of cells observed 
after Y-27632. It can be surmised that the transplanted 
islets of the nonuse group could not maintain a consis-
tent thickness due to apoptosis. Insulin expression was 
uniform in the Y-27632 group, but was only observed in 
Figure 3. Viability of islets after 7 days in culture. A live/dead viability cytotoxicity kit was used to test the viability of the islets in the 
absence or presence of Y-27632. Green calcein-AM staining demonstrates living cells, whereas red ethidium  homodimer-1 staining 
 indicates dead cells. This demonstrated the survival of cells even after 7 days of culture. Scale bars: 200 mm.
Figure 4. Glucose-responding insulin secretion of islets. The 
Y-27632 group was shown to significantly secrete more insulin 
than the control group (p < 0.01). Y-27632 group: n = 5. Control 
group: n = 5. Data are expressed as the mean ± SE.
Figure 5. RT-PCR of islets. The strong expression of B-cell 
CLL/lymphoma 2 (Bcl-2) and lower expression of Bcl2-
associated X protein (Bax). Bax observed with Y-27632 dem-
onstrates inhibition of apoptosis compared to the absent Bcl-2 
and higher Bax levels seen in controls.
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a portion of the transplanted islets in the control group 
(Fig. 6). Y-27632 inhibited cell apoptosis in a graft and 
was also indicated as effective in insulin secretion. In the 
Y-27632-treated islets, uniform and satisfactory function 
of the islets following transplantation was apparent, and 
this matches the effective use of Y-27632 in vitro.
DISCUSSION
Cell transplantation has been receiving attention as a 
treatment for patients with neurodegenerative diseases 
such as stroke, spinal cord injury, and Parkinson’s disease, 
and extensive transplant research has been conducted in 
an attempt to restore neurological function, which has 
Figure 6. Transplantation of islets. Hematoxylin–eosin (H&E) staining demonstrated that the graft in the Y-27632 group was of a 
consistent thickness (A) and regular adhesion (B) compared with the sparse and random adhesion of the control group. Uniform insu-
lin staining was observed with the Y-27632 group compared to the control group, insulin expression only being seen in a segregated 
 portion of the transplanted islets in the control group. Scale bars: 10 mm or 50 mm as depicted.
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been lost in these patients (3,8,10,29). However, many cell 
grafts suffer apoptosis several days after transplantation 
as a result of cell separation, cessation of nutrition, oxi-
dative stress, agitation death, and low oxygen (7,25,33). 
With respect to human embryonic stem (ES) cells dur-
ing separation and subculture, ROCK inhibitor Y-27632 
has been reported to inhibit apoptosis (programmed cell 
death) due to variance (31). In human ES cell-derived 
neurons during cell separation and subculture, when 
the selective inhibitor Y-27632 of ROCK was used, cell 
death by human ES cell variance was strongly inhibited, 
and the colony creation rate from one cell was reported to 
accelerate by 30%. The idea that the factors within cells 
that govern apoptosis in a dispersion culture of human ES 
cells are not generally related to cell death due to ROCK 
has been verified for the first time. In addition, Y-27632 is 
known to possess the effect of inhibiting cancer cell infil-
tration and control of cell differentiation, and contraction 
of the vascular smooth muscle by cascade signaling of 
ROCK. With Y-27632 already having drug approval as a 
vasodilator, there is a large advantage in using Y-27632 
for the practical application of BAP from a regulatory 
point of view. Also, Y-27632 is known to inhibit cyto-
toxicity in brain cells and possess tissue regeneration 
effects (6). However, there have been no reports related 
to the usefulness of Y-27632 in islet cultures. Therefore, 
we studied the usefulness of Y-27632 using rat islets and 
its morphological assessment, insulin secretion function 
assessment, and the comparative evaluation of Bax and 
Bcl-2 expressions that are apoptosis-related molecules.
Morphologically, on the third day of culture, cell mem-
brane blebbing was observed in the islets from the control 
group, and the cell membrane border took on an irregular 
shape, with particle massing of the islets starting to occur. 
However, with the Y-27632 use group, such blebbing 
was inhibited and the cell form was satisfactorily main-
tained even after 7 days of culture. Bax expression was 
suppressed in the group using Y-27632, and Bcl-2 was 
strongly expressed. In addition, with the use of ROCK 
inhibitor Y-27632, inhibiting effects of apoptosis not 
only were observed, but the possibility of increasing the 
glucose-responsive insulin secretory function was deter-
mined. Currently, this mechanism is being studied. With 
the islets of the Y-27632 use group, it was suggested that 
the islet function was therefore uniform and satisfactory 
after transplantation. The performance of this transplant 
experiment matches the results of Y-27632 use in vitro.
Until now, there have been no reports of the useful-
ness of Y-27632 related to islet culture. To summarize our 
study results with the studies related to the effectiveness 
of Y-27632 on other cell types, we would like to propose 
a mechanism of effectiveness with respect to the islet cul-
ture of Y-27632, as shown in Figure 7. ROCK is a protein 
kinase that is activated by the Rho kinase that exists in the 
cytoplasm, and when ROCK is activated, MLC is directly 
phosphorylated, or the deactivation of myosin phosphatase 
causes an indirect increase of MLC phosphorylation, and 
membrane blebbing occurs. This causes contraction of the 
cells and is known to trigger apoptosis (13). Generally, 
apoptosis is regulated by the endogenous system (depend-
ing on the mitochondria) and the extrinsic (depending on 
the death receptor) channels (1,27,30). In the endogenous 
system pathway, cytochrome c is released from mito-
chondria by oxidants or DNA damage, toxins, anoxia, 
and pressurization, and the activation of caspase 3, 6, and 
7 leads to apoptosis. On the other hand, with extrinsic 
pathways, caspase 8 is activated through death receptors 
such as tumor necrosis factor (TNF) or Fas ligand (FasL), 
and caspase 3, 6, and 7 are activated, leading to apop-
tosis (2,15,24). Although a clear report has not yet been 
reported regarding the mechanism of ROCK inhibitors, by 
using a ROCK inhibitor before Rho is activated, blebbing 
of the cell membrane is prevented, and it is known from 
recent research that apoptosis can be inhibited (5,14). 
Once ROCK is activated, cell contraction, dramatic mem-
brane blebbing, nucleus decay, and cell fragmentation 
occur (22,24). However, the ROCK inhibitor causes vari-
ous conditions that may reduce the apoptosis level in cer-
tain cells and tissue types, or lead (28) to apoptosis, with 
reports that in certain states the activation of ROCK or the 
inhibition of ROCK has no involvement with apoptosis 
(24), and thus, the clarification of the functions related to 
the signal pathway of ROCK is needed.
In addition, when BAP use in a human is considered, 
the cell source to be placed into the bag will be a problem. 
Problems such as ethical issues related to heterologous 
cell transplantation, problems with cell amounts to pro-
duce a sufficient effect, and the functional maintenance of 
sufficient cell survival within the bag must be considered. 
Although cells originating from humans are obviously 
preferred when considering ethical issues, transplant 
offers from brain-dead donors must currently be solely 
relied upon, with the current status of one recipient requir-
ing numerous donors, resulting in a serious problem with 
the lack of donors. Human ES cells and induced pluripo-
tent stem (iPS) cells may eliminate this problem. With 
regard to human ES cells, Watanabe et al. announced that 
by combining with Y-27632, apoptosis could be inhib-
ited during cell separation and subculture, and its effec-
tiveness was verified (31). In addition, with regard to 
human iPS cells, there have been reports of satisfactory 
cryopreservation and increased cell survival and colony 
amount by combining such cells with Y-27632 (4).
In addition, in order to ensure adequate cell amounts, 
the establishment of human insulin-secreting cell stock 
will likely be needed. In order to achieve that during sub-
culture and cryopreservation, Y-27632 will be effectively 
used for the long-term maintenance of cell survival and 
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function and is anticipated in helping islet transplanta-
tion therapy. Once the cell source has been resolved, a 
system will be developed to culture large amounts of 
insulin- secreting cells, and its use in various treatments 
in various circles is anticipated. In order to achieve this, 
the development of technology will be required to effec-
tively cryopreserve large amounts of cells, and a system 
constructed to deliver those cells to all regions will be 
needed. In this study, the effect of apoptosis inhibition 
in an islet culture was observed with a ROCK inhibitor 
Y-27632. ROCK inhibitors are already being clinically 
used in brain/vascular patients and in the ophthalmologic 
field as a vasodilator, and a future clinical application 
of the BAP will have the benefit of not having to over-
come any regulatory hurdles. Although further studies 
are needed related to the administered pathway of ROCK 
inhibitors before donor separation or immediately after 
separation of the cells, the effective use of ROCK inhibi-
tors as apoptosis inhibitors is anticipated for the future.
In this study, we were able to confirm effective mor-
phological and functional culture maintenance by separat-
ing islets from a rat and adding ROCK inhibitor Y-27632 
to the medium. Based on rat islet separation and a func-
tional culture, it is believed that it will be helpful in the 
clinical use of the BAP.
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